The hepatitis B virus X gene product transactivates the HIV-LTR in vivo.

C. Balsano, O. Billet, M. Bennoun, C. Cavard, A. Zider, G. Grimber, G. Natoli, P. Briand, M. Levrero

Research output: Contribution to journalArticlepeer-review


It has previously been shown that the hepatitis B virus (HBV) X gene product, HBx, transactivates homologous and heterologous transcriptional regulatory sequences of viruses, including the human immunodeficiency virus type 1 (HIV1) long terminal repeat (LTR), and various cellular genes in vitro. To evaluate the transactivating function of HBx in vivo, we generated transgenic mice carrying the X open reading frame under the control of the human antithrombin III (ATIII) gene regulatory sequences. These mice express the 16 Kd HBx protein in the liver, as demonstrated by immunoprecipitation studies. Crossbreeding of HBx mice with transgenics carrying either the chloramphenicol acetyl transferase (CAT) bacterial or the lacZ reporter gene driven by the HIV1-LTR allowed us to demonstrate, for the first time, the in vivo transactivating function of HBx protein.

Original languageEnglish
Pages (from-to)63-71
Number of pages9
JournalArchives of virology. Supplementum
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Immunology and Microbiology(all)


Dive into the research topics of 'The hepatitis B virus X gene product transactivates the HIV-LTR in vivo.'. Together they form a unique fingerprint.

Cite this